Home » Topics » Regulatory » Patents

Patents
RSS

HMR presents new agents for lipid disorders

Nov. 2, 1998

New K+ channel blockers for arrhythmias, ulcers and related disorders

Nov. 2, 1998

Aminoacyl sulfamides synthesized at Cubist claimed for psoriasis

Nov. 2, 1998

Novel vitamin D compounds claimed for use in bone disorders and psoriasis

Oct. 30, 1998

Camptothecin analogues and prodrugs described in patent literature by SCRAS

Oct. 30, 1998

Neuroprotective indolomorphinane derivatives under development at Toray

Oct. 30, 1998

Ajinomoto prepares extensive series with anticoagulant efficacy

Oct. 30, 1998

Thiocarbamic acid derivatives as inhibitors of squalene epoxidase

Oct. 29, 1998

Astra's new antiasthmatic, antirhinitic agents

Oct. 29, 1998

Difluoronucleoside antineoplastic and antiherpesvirus agents from Lilly

Oct. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...